Literature DB >> 9359503

Sibling allogeneic bone marrow transplantation in a patient with type I Glanzmann's thrombasthenia.

M D McColl1, B E Gibson.   

Abstract

Glanzmann's thrombasthenia is a rare inherited bleeding disorder caused by either quantitative or qualitative abnormalities of the platelet membrane glycoprotein (Gp) IIb/IIIa complex. Bleeding is usually mucocutaneous in origin and may be of a severe nature. We report the use of allegeneic bone marrow transplantation in a 5-year-old child with homozygous type I Glanzmann's thrombasthenia, using the patient's younger brother as marrow donor. Engraftment was successful and has resulted in a resolution of bleeding episodes. We conclude that allogeneic BMT is a potentially curative option for those with Glanzmann's thrombasthenia associated with severe bleeding symptoms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9359503     DOI: 10.1046/j.1365-2141.1997.3533167.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Glanzmann thrombasthenia with acute myeloid leukemia successfully treated by bone marrow transplantation.

Authors:  Tetsuro-Takahiro Fujimoto; Miho Kishimoto; Kazuko Ide; Miyoko Mizushima; Masashi Mita; Nobuo Sezaki; Kensuke Kojima; Katsuji Shinagawa; Kenji Niiya; Mitsune Tanimoto; Kingo Fujimura
Journal:  Int J Hematol       Date:  2005-01       Impact factor: 2.490

Review 2.  Glanzmann's thrombasthenia.

Authors:  M S Tullu; P S Dixit; S B Nair; J R Kamat; R K Vaswani; S D Shetty; A R Pawar
Journal:  Indian J Pediatr       Date:  2001-06       Impact factor: 1.967

3.  Allogeneic hematopoietic cell transplantation in an adult patient with Glanzmann thrombasthenia.

Authors:  Ana R Cid; Pau Montesinos; Isabel Sánchez-Guiu; Saturnino Haya; Jose I Lorenzo; Jaime Sanz; Federico Moscardo; Nieves Puig; Dolores Planelles; Santiago Bonanad; Guillermo F Sanz; Vicente Vicente; Consuelo González-Manchón; María L Lozano; José Rivera; Miguel A Sanz
Journal:  Clin Case Rep       Date:  2017-10-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.